Coronavirus weekly round-up: Gilead drug trial excites markets but US growth falls 4.8%
Five investors mull the events shaping portfolios over the past week
Five investors mull the events shaping portfolios over the past week
In the latest in our occasional spotlights on less traditional assets, Olly Hughes highlights the uncorrelated nature and ESG credential of commercial forestry assets
Merian fund manager praises Legal & General for telling dividend naysayers to ‘bog off’
Small group of Investment Association funds have sizeable weightings in the video conferencing stock
Fundsmith founder reveals the one type of business investors should consider for dividends
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
Coronavirus flows lag other regions as Mifid II changes fail to convince investors on ETF liquidity
Rachel Beagles joins board as scion of investment trust’s founding family steps back
Carmignac’s European Leaders manager is trying to limit screen time as markets reel from Covid-19
Steep market falls can put immense pressure upon investors but simple techniques can offer some protection
Nick Train and Michael Lindsell boutique is D2C’s second largest shareholder behind Peter Hargreaves
‘Usually the management buy shares as this means they partake in the long term growth of a business’